InsidersTradesSigma
Explore the complete record of transactions filed by Zhang Jack Y., Director General. Officer active across 1 company, notably Amphastar Pharmaceuticals, Inc.. Aggregated, 5 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €4m. Activity tracked since 15 March 2022. The latest transaction was filed on 20 May 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 de 5 declaraciones
Jack Y. Zhang is the CEO & Chief Scientific Officer at Amphastar Pharmaceuticals, Inc. He is responsible for the strategic leadership and scientific initiatives of the company. With expertise in the pharmaceutical sector, Jack Y. Zhang plays a key role in developing new therapies and optimizing research processes. His commitment to innovation and research is essential for Amphastar's success.